CUE

CUE BIOPHARMA INC

CUE·22978P205·US·Common Stock-13D/G

CUE (CUE BIOPHARMA INC) is held by 30 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($565,214), GEODE CAPITAL MANAGEMENT, LLC ($244,800), VANGUARD FIDUCIARY TRUST CO ($125,025). Net institutional sentiment: Mixed.

30
Holders
(2 Elite)
$1.3M
Total Value
52% (23)
Consensus
12 buying - 11 selling
13F: Insider & Congress: Updated regularly
CUE

Smart Money Verdict

View all
Loading verdict
Held by 30 funds
2 elite

Who's Trading

Source dates: Price Aug 14, 2026 · Insiders May 7, 2026 · Activists Aug 14, 2026 · Congress none

ActivistDRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC7.0%Aug 14, 2026
InsiderLSLin Shao-LeeVest 328K shMay 3, 2026
ActivistMEMark E. Strome5.0%May 16, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
2.5M$565,2140.0%+395.65%
37
Increased
1.1M(+32.5%)$244,8000.0%-67.57%
20
New
543,585$125,0250.0%+395.65%
34
Decreased
449,161$103,2610.0%+4.59%
0
Unchanged
246,556$56,6830.0%-73.73%
0
Decreased
213,828(-10.3%)$49,1590.0%+59.63%
0
Increased
207,708(+0.1%)$47,5650.0%+4.67%
14
Unchanged
179,353$41,2330.0%-53.77%
0
Decreased
94,607(-6.3%)$21,7500.0%-69.37%
0
Increased
88,350(+88.6%)$20,3200.0%+33.18%
20
Unchanged
79,500$18,2770.0%+58.37%
0
Increased
34,151(+137.6%)$7,8510.0%+92.65%
18
Decreased
24,614(-85.4%)$5,6590.0%+67.80%
0
Unchanged
20,000$4,5980.0%+51.37%
0
Decreased
18,374(-1.2%)$4,2240.0%-6.98%
0
Decreased
15,590(-66.4%)$3,5840.0%-9.08%
0
New
15,124$3,4770.0%+395.65%
19
New
12,997$2,9890.0%+395.65%
20
New
10,000$2,2990.0%+395.65%
18
Unchanged
6,029$1,3860.0%-69.25%
0

Showing 1-20 of 33

1 / 2
CUECUECUE BIOPHARMA INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used